Guidance on the safety assessment of nanomaterials in cosmetics

2 About the Scientific Committees Three independent non-food Scientific Committees provide the Commission with the scientific advice it needs when preparing policy and proposals relating to consumer safety, public health and the environment. The Committees also draw the Commission's attention to the new or emerging problems which may pose an actual or potential threat. SCCS The Committee shall provide opinions on questions concerning all types of health and safety risks (notably chemical, biological, mechanical and other physical risks) of non-food consumer products (for example: cosmetic products and their ingredients, toys, textiles, clothing, personal care and household products such as detergents, etc.) and services (for example: tattooing, artificial sun tanning, etc.).The opinions of the Scientific Committees present the views of the independent scientists who are members of the committees. They do not necessarily reflect the views of the European Commission. The opinions are published by the European Commission in their original language only.

[1]  Worth Andrew,et al.  Alternative (Non-Animal) Methods for Chemicals Testing: Current Status and Future Prospects (A Report Prepared by ECVAM and the ECVAM WG on Chemicals) , 2002 .

[2]  Lutz Müller,et al.  Photochemical genotoxicity: principles and test methods. Report of a GUM task force. , 2004, Mutation research.

[3]  P. Kasper,et al.  Use of the photo-micronucleus assay in Chinese hamster V79 cells to study photochemical genotoxicity. , 2002, Mutation research.

[4]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[5]  Nathalie Tufenkji,et al.  Characterizing manufactured nanoparticles in the environment: multimethod determination of particle sizes. , 2009, Environmental science & technology.

[6]  Wim H de Jong,et al.  The status of in vitro toxicity studies in the risk assessment of nanomaterials. , 2009, Nanomedicine.

[7]  Manuela Semmler-Behnke,et al.  Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.

[8]  S Albertini,et al.  Photomutagenesis test development: I. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in bacterial and yeast assays. , 1993, Mutation research.

[9]  Günter Oberdörster,et al.  Nanoparticles and the brain: cause for concern?. , 2009, Journal of nanoscience and nanotechnology.

[10]  OECD Environmental Health and Safety Publications , 2008 .

[11]  Jürgen Seitz,et al.  Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs , 2009, Inhalation toxicology.

[12]  Catrin Albrecht,et al.  Cellular responses to nanoparticles: Target structures and mechanisms , 2007 .

[13]  Vera Rogiers,et al.  Good Science Must be the Key Factor in the Development and Use of Alternative Methods for Safety Assessment of Cosmetics , 2006 .

[14]  W. D. de Jong,et al.  The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.

[15]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[16]  Manuela Semmler-Behnke,et al.  Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  N. Monteiro-Riviere,et al.  Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.

[18]  J. Dresp,et al.  Photomutagenesis test development: II. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in chromosomal aberration assays using CHO cells. , 1993, Mutation research.

[19]  Peter Wick,et al.  Nanomaterial cell interactions: are current in vitro tests reliable? , 2011, Nanomedicine.

[20]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[21]  E. Joner,et al.  Conceivable interactions of biopersistent nanoparticles with food matrix and living systems following from their physicochemical properties , 2008 .

[22]  Morteza Mahmoudi,et al.  Protein-Nanoparticle Interactions , 2013 .

[23]  Marianne Geiser,et al.  Deposition and biokinetics of inhaled nanoparticles , 2010, Particle and Fibre Toxicology.

[24]  Masatoshi Hoya,et al.  Modified short‐term guinea pig sensitization tests for detecting contact allergens as an alternative to the conventional test , 2001, Contact dermatitis.

[25]  Sophie Lanone,et al.  Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines , 2009, Particle and Fibre Toxicology.

[26]  Andrew P. Worth,et al.  QSAR modeling of nanomaterials. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[27]  Soyoung Lee,et al.  The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. , 2011, Biomaterials.

[28]  S Albertini,et al.  The photomutagenicity of fluoroquinolones and other drugs. , 1998, Toxicology letters.

[29]  S Albertini,et al.  The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). , 1996, Mutagenesis.

[30]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[31]  D. Averbeck,et al.  Genetic effect of 3-carbethoxypsoralen, angelicin, psoralen and 8-methoxypsoralen plus 365-nm irradiation in Saccharomyces cerevisiae: induction of reversions, mitotic crossing-over, gene conversion and cytoplasmic "petite" mutations. , 1979, Mutation research.

[32]  Michael Balls,et al.  A Study on UV Filter Chemicals from Annex VII of European Union Directive 76/768/EEC, in the In Vitro 3T3 NRU Phototoxicity Test , 1998, Alternatives to laboratory animals : ATLA.

[33]  M Balls,et al.  Progress toward the Validation of Alternative Tests , 1997, Alternatives to laboratory animals : ATLA.

[34]  G W Halbert,et al.  The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats , 1989, The Journal of pharmacy and pharmacology.

[35]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[36]  Lucas Smith,et al.  Classification, packaging and labelling of dangerous substances , 2014 .

[37]  Jerzy Leszczynski,et al.  Multiplicative SMILES-based optimal descriptors: QSPR modeling of fullerene C60 solubility in organic solvents , 2007 .

[38]  J. Leszczynski,et al.  A new approach to the characterization of nanomaterials : Predicting Young's modulus by correlation weighting of nanomaterials codes , 2006 .

[39]  Qasim Chaudhry,et al.  A complementary definition of nanomaterial , 2010 .

[40]  Jerzy Leszczynski,et al.  Predicting thermal conductivity of nanomaterials by correlation weighting technological attributes codes , 2007 .

[41]  Martin J. D. Clift,et al.  Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative , 2010, Archives of Toxicology.

[42]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[43]  Qasim Chaudhry,et al.  The Current Risk Assessment Paradigm in Relation to the Regulation of Nanotechnologies , 2010 .

[44]  Markus Schulz,et al.  Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.

[45]  Alok Dhawan,et al.  A flow cytometric method to assess nanoparticle uptake in bacteria , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[46]  Verena Wilhelmi,et al.  Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefacts. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[47]  TG 442D.  OECD GUIDELINE FOR THE TESTING OF CHEMICALS In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method , 2000 .

[48]  I. Ivanov,et al.  Comparative Study of Predictive Computational Models for Nanoparticle‐Induced Cytotoxicity , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[49]  Aldert H Piersma,et al.  In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. , 2009, Toxicology and applied pharmacology.

[50]  Gyula Dura,et al.  Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments , 2012, Journal of applied toxicology : JAT.

[51]  Antonio Marcomini,et al.  Influence of serum on in situ proliferation and genotoxicity in A549 human lung cells exposed to nanomaterials. , 2012, Mutation research.

[52]  Jerzy Leszczynski,et al.  Predicting water solubility and octanol water partition coefficient for carbon nanotubes based on the chiral vector , 2007, Comput. Biol. Chem..

[53]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[54]  Stergios Logothetidis.  Nanomedicine and Nanobiotechnology , 2012 .